Skip to content

Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation

Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842062
Enrollment
380
Registered
2009-02-12
Start date
2009-02-28
Completion date
2012-01-31
Last updated
2015-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Rhytides

Brief summary

A prospective, non-randomized study to evaluate the performance of the MyoScience Tissue Remodeling Device for the treatment of glabellar lines (frown lines), lateral orbital lines (crow's feet), and frontalis lines (horizontal forehead lines).

Interventions

DEVICEMyoScience Tissue Remodeling Device

Percutaneous treatment with the MyoScience device

Sponsors

Pacira Pharmaceuticals, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* The subject must be a female 30 to 70 years of age. * The subject must have a clinical examination prior to treatment including assessment of hyperdynamic line severity. * The subject must have a wrinkle rating of at least 1 at rest in one or more of the following treatment areas (glabellar, lateral orbital, or frontalis). * The subject must have signed an informed consent form. * The subject should not have undergone any other facial cosmetic procedures at or above the level of the cheekbones within the past 6 months. * The subject should not be participating in any other facial cosmetic research study.

Exclusion criteria

* The subject is on a regular regimen of prescribed or over-the-counter anticoagulants. * The subject has an infection or skin problem at the injection site. * The subject has a history of facial nerve palsy. * The subject has marked facial asymmetry. * The subject has ptosis. * The subject has excessive dermatochalasis. * The subject has deep dermal scarring. * The subject has thick sebaceous skin. * The investigator is unable to substantially lessen facial lines by physical separation. * The subject has a history of neuromuscular disorder. * The subject has undergone prior surgery that alters the subcutaneous anatomy of the areas being treated. * Subjects with laxity of the canthal tendon and/or with lower lid retraction, and subjects who recruit their zygomaticus major muscle to animate their crow's feet. * The subject has any physical or psychiatric condition that in the investigator's opinion would warrant exclusion from the study or prevent the subject from completing the study.

Design outcomes

Primary

MeasureTime frame
Investigators' and subjects'rating of line severity in the target areas at rest and in animation at each follow-up interval.Up to 6 months

Secondary

MeasureTime frame
Incidence of adverse eventsUp to 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026